Skip to main content

Table 1 Baseline characteristics of the studied cohort relative to the presence of events

From: Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction

Variable

All patients

(n = 1085)

Without events

(n = 909)

With events

(n = 176)

p value

Age (years)

62 (52–73)

59 (51–69)

76 (66–81)

< 0.001

Female

241 (22.2)

187 (20.6)

54 (30.7)

0.003

Hypertension

598 (55.1)

473 (52.0)

125 (71.0)

0.001

Diabetes mellitus

276 (25.4)

208 (22.9)

68 (38.6)

< 0.001

Dyslipidemia

645 (59.5)

550 (60.5)

95 (54.0)

0.106

Cerebrovascular disease

69 (6.4)

42 (4.6)

27 (15.3)

< 0.001

Peripheral arterial disease

77 (7.1)

57 (6.3)

20 (11.4)

0.016

Heart failure

18 (1.7)

7 (0.8)

11 (6.3)

< 0.001

Coronary artery disease

236 (21.8)

188 (20.7)

48 (27.3)

0.052

Myocardial infarction

103 (9.5)

76 (8.4)

27 (15.3)

0.004

Killip–Kimball I–II

1009 (93.0)

877 (96.5)

132 (75.0)

< 0.001

Killip–Kimball III–IV

76 (7.0)

32 (3.5)

44 (25.0)

< 0.001

BMI (kg/m2)

27.3 (24.8–29.9)

27.2 (24.8–29.8)

27.6 (24.3–30.0)

0.944

Hs-TnT, peak (ng/L)

2752 (1021–6057)

2643 (934–5590)

4375 (1357–91,485)

< 0.001

NT-ProBNP, peak (ng/L)

1003 (395–2421)

827 (356–1707)

3461 (1569–7396)

< 0.001

LVEF (%)

52 (45–58)

54 (47–59)

45 (38–53)

< 0.001

Main epicardial coronary arteries > 70% stenosis

 1

564 (52.0)

493 (54.2)

71 (40.3)

0.001

 2

287 (26.5)

253 (27.8)

34 (19.3)

0.019

 3

212 (19.5)

155 (17.1)

57 (32.4)

< 0.001

Left main ≥ 50% stenosis

40 (3.7)

25 (2.8)

15 (8.5)

< 0.001

  1. Data represent the number (%) or median (interquartile range). Wilcoxon Rank-sum test was used for comparisons of continuous variables
  2. PCI percutaneous coronary intervention, BMI body mass index, hs-TnT high-sensitivity troponin T, LVEF left ventricular ejection fraction